Byrne Asset Management’s Lexaria Bioscience LEXX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$29.8K	Buy	34,209 +5,304	+18%	+$4.62K	0.02%	301
2025 Q1	$49.4K	Buy	28,905 +15,905	+122%	+$27.2K	0.04%	210
2024 Q4	$27.3K	Buy	13,000 +7,400	+132%	+$15.5K	0.02%	251
2024 Q3	$17.1K	Buy	+5,600	New	+$17.1K	0.01%	323